Back to User profile » Dr Hongjie Qian
Paper published by Dr Hongjie Qian:
Original Research
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects
Qian H, Chen Q, Liang L, Zou Y, Pu H, Xin L, Song R, Li T, Zhu H, Wang Y, Tian G, Shen J, Jiang H, Yu C, Wang Z, Jia J
Drug Design, Development and Therapy 2021, 15:2947-2959
Published Date: 6 July 2021